JJ

John Janczy

Head of R&D at Nanoly

Dr. Janczy has over 6 years of experience in inflammation and immunology research. His work has focused primarily on pathogen recognition and the modulation of innate and adaptive immune responses. Two of his most recent publications are: “Immune complexes inhibit IL-1 secretion and inflammasome activation” (Journal of Immunology) and “Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation” (Immunity).

Timeline

  • Head of R&D

    Current role